课题基金 / 基金详情

CLINICAL TRIAL: PHASE I/II MULTICENTER,OPEN LABEL,NONCOMPARITIVE STUDY OF HIV AF

CLINICAL TRIAL: PHASE I/II MULTICENTER,OPEN LABEL,NONCOMPARITIVE STUDY OF HIV AF
临床试验：I/II 期多中心、开放标签、HIV AF 非比较研究
批准号：
7950832
负责人：
Sharon A Nachman
金额：
$1.92万
依托单位：
STATE UNIVERSITY NEW YORK STONY BROOK
依托单位国家：
美国
项目类别：
财政年份：
2008
资助国家：
美国
项目状态：
已结题
起止时间：
2008-12-01 至 2009-11-30
来源：
https://reporter.nih.gov/project-details/7950832
关键词：
AdolescentChildClinical ResearchClinical TrialsComputer Retrieval of Information on Scientific Projects DatabaseFundingGrantHIVInstitutionPhaseResearchResearch PersonnelResourcesSafetySourceStagingUnited States National Institutes of Healthage groupopen label

项目摘要

项目成果

Sharon A Nachman的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. 1. In Stage I, to evaluate the short term safety and tolerability of raltegravir, in HIV infected children and adolescents, added to an initial stable background therapy* which will then be optimized in children and adolescents in the age groups of =2 to <6, =6 to <12 and =12 to <19 years.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
LOC-IMPAACT Leadership GroupPharmacokinetics and Safety of Remdesivir for Treatment of COVID-19 in Pregnant Women in the US
  • 批准号：
    10174121
  • 项目类别：
  • 资助金额：
    $94.26万
  • 财政年份：
    2020
  • 负责人：
    Sharon A Nachman
  • 依托单位：
    JOHNS HOPKINS UNIVERSITY
SURVEILLANCE MONITORING FOR ART TOXICITIES
CLINICAL TRIAL: PHASE I/II STUDY OF SAFETY AND IMMUNOGENICITY OF QUADRIVALENT ME
CLINICAL TRIAL: PSYCHIATRIC CO-MORBIDITY IN PERINATALLY HIV-INFECTED CHILDREN AN
海外基金